z-logo
open-access-imgOpen Access
Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review.
Author(s) -
Tessa Nalven,
Nichea S. Spillane,
Melissa R. Schick,
Lisa L. Weyandt
Publication year - 2021
Publication title -
experimental and clinical psychopharmacology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.066
H-Index - 92
eISSN - 1936-2293
pISSN - 1064-1297
DOI - 10.1037/pha0000510
Subject(s) - naltrexone , buprenorphine , randomized controlled trial , medicine , ethnic group , inclusion (mineral) , methadone , socioeconomic status , gerontology , clinical psychology , demography , psychology , psychiatry , opioid , population , environmental health , social psychology , sociology , receptor , anthropology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom